作者
Marcel Razpotnik,C Jürgensen,Michael J. Sigal,Ö Çelebi,Federica Branchi,Andreas Adler,Juliane Buchkremer,Frank Tacke,Alexander Wree
摘要
Aims Previous studies have demonstrated that infected pancreatic fluid collections are associated with poorer clinical outcomes. In light of the global rise in antibiotic resistance, this study evaluates the impact of infecting microorganisms on the effectiveness of EUS- guided drainage of pancreatic necrotic collections. Methods Data on EUS- guided drainage of pancreatic necrotic collections performed between 2018 and 2023 across three endoscopy units at Charité Berlin, irrespective of etiology, were collected. The clinical endpoints evaluated included hospital and ICU length of stay, the total number of interventions necessary to achieve treatment success- including initial procedures, stent removal/ replacement, and additional interventions such as necrosectomy or complication management- clinical success of EUS therapy, defined as resolution of the collection to<50% within 3 months based on follow-up imaging and clinical improvement, and 12-month mortality. Infection and microorganism type, including antibiotic resistance, were diagnosed based on clinical presentation, microbiological evidence, and Gram staining from puncture aspirates or blood cultures, with other potential infection sources systematically excluded. Patients with sterile necrotic collections undergoing the same therapeutic modality were used as a control group to compare the outcomes. Results A total of 356 patients (71.3% male, 55.6±14.1 years) were included in the final analysis. In 309 cases (86.8%), double pigtail plastic stents were utilized (38.2% were multiple), and in 108 patients (30.3%), a direct endoscopic necrosectomy was performed. In 40.4% of cases, penicillin; 37.9%, carbapenems; 20.8%, vancomycin; 18%, cephalosporins; 16.6%, antifungals; 12.1%, metronidazole; and 9.3%, other antibiotics were administered. Compared to the control group, infected necrotic collections, particularly those with Gram-positive microorganisms, were associated with significantly prolonged hospital stay (31 vs. 15.5 days, p<0.001) and increased ICU utilization (13 vs. 3 days, p<0.001). Among the 19 microorganism types analyzed, Enterococcus faecium and Enterococcus faecalis, including 12 cases with Vancomycin-resistant Enterococci (VRE), were linked to significantly worse outcomes than others. Enterococcus faecalis infection was associated with prolonged hospital stay (52.5 vs. 15.5 days), extended ICU stay (32.5 vs. 3 days), and an increased number of interventions (6.5 vs. 3), all p<0.001. Mortality was notably higher in the Enterococcus faecium group (23.5% vs. 2.5%, p<0.001), and this association remained significant in multivariate logistic regression analysis, with an OR of 5.7 (95% CI: 2.0-16.1; p<0.001). Conclusions The infecting microorganism significantly impacts clinical outcomes in patients undergoing EUS-guided therapy of pancreatic fluid collections. Infections with Enterococcus faecalis and Enterococcus faecium are associated with poorer outcomes and higher mortality, emphasizing the need for targeted therapeutic strategies. Publication History Article published online: 27 March 2025 © 2025. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany